Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation

British Journal of Cancer

Volumn 89, Issue 6, 2003, Pages 1096-1101

  Marsh, H P ^a,b   Haldar, N A ^a   Bunce, M ^a   Marshall, S E ^a   Le Monier, K ^a   Winsey, S L ^a   Christodoulos, K ^b   Cranston, D ^a   Welsh, K I ^a,c   Harris, A L ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Bladder cancer; Grade; Polymorphisms; TNF

Indexed keywords

DNA; TUMOR NECROSIS FACTOR;

ADULT; AGED; ALLELE; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; MALE; POLYMERASE CHAIN REACTION; POLYMORPHIC LOCUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 0141990968     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601165     Document Type: Article

References (34)

1. Editorial (1999) Freely associating [comment]. Nat Genet 22: 1-2
2. Allen RD (1999) Polymorphism of the human TNF-alpha promoter-random variation or functional diversity? Mol Immunol 36: 1017-1027
3. Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357: 539-545
4. Bidwell J, Keen L, Gallagher G, Kimberly RTH, Mcdermott MF, Oskenberg J, McNicholl J, Pociot F, Hardt C, D'Alfonso S (1999) Cytokine gene polymorphism in human disease: on line databases. Genes Immun 1: 3-19
5. Bunce M, Barnardo MC, Procter J, Marsh SG, Vilches C, Welsh KI (1996) High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology (corrected and republished in Tissue Antigens 1997 Jul;50(1):100-111). Tissue Antigens 48: 680-691
6. Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ, Welsh KI (1995) Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46: 355-367
7. Davies FE, Rollinson SJ, Rawstron AC, Roman E, Richards S, Drayson M, Child JA, Morgan GJ (2000) High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. J Clin Oncol 18: 2843-2851
8. Fanning GC, Bunce M, Black CM, Welsh KI (1997) Polymerase chain reaction haplotyping using 3′ mismatches in the forward and reverse primers: application to the biallelic polymorphisms of tumour necrosis factor and lymphotoxin alpha. Tissue Antigens 50: 23-31
9. Gallagher G, Lindemann M, Oh H-H, Ferencik S, Walz MK, Schmitz A, Richards S, Eskdale J, Field M, Grosse-Wilde H (1997) Association of the TNFa2 microsatellite allele with the presence of colorectal cancer. Tissue Antigens 50: 47-51
10. Hassen W, Droller MJ (2000) Current concepts in assessment and treatment of bladder cancer. Curr Opin Urol 10: 291-299
11. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 5′-flanking region of the human tumour necrosis factor (TNF)-alpha gene in Japanese. Tissue Antigens 51: 605-612
12. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ (2003) Cancer statistics, 2003. CA Cancer J Clin 53: 5-26
13. Kaijzel EL, van Krugten MV, Brinkman BMN, Huizinga TWJ, van der Straaten T, Hazes JMW, Ziegler-Heitbrock HWL, Nedospasov SA, Breedveld FC, Verweij CL (1998) Functional analysis of a human tumour necrosis factor alpha (TNF-alpha) promoter polymorphism related to joint damage in rheumatoid arthritis. Mol Med 4: 724-733
14. Leek, RL, Fox SB, Ng F, Harris AL, Lewis CE (1998) Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma. Br J Cancer 77: 2246-2251
15. Locke JR, Hill DE, Walzer Y (1985) Incidence of squamous cell carcinoma in patients with long term catheter drainage. J Urol 133: 1034
16. Marshall SE, Bordea C, Haldar NA, Mullighan CG, Wojnarowska F, Morris PJ, Welsh KI (2000) Glutathione S-transferase polymorphisms and skin cancer after renal transplantation. Kidney Int 58: 2186-2193
17. Matthias C, Jahnke V, Fryer A, Strange R, Ollier W, Hajeer A (1998) Influence of tumour necrosis factor microsatellite polymorphisms on susceptibility to head and neck cancer. Acta Otolaryngol 118: 284-288
18. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G, Balkwill F (1999) Mice deficient in tumour necrosis factor alpha are resistant to skin carcinogenesis. Nat Med 5: 828-831
19. Mullighan CG, Fanning G, Chapel HM, Welsh KI (1997) TNF and lymphotoxin alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J Immunol 159: 6236-6241
20. Naylor MS, Stamp GWH, Foulkes WD, Eccles D, Balkwill F (1992) Tumour necrosis factor and its receptors in human ovarian cancer - potential role in disease progression. J Clin Invest 91: 2194-2206
21. O'Brien T, Fox SB, Dickinson AJ, Turley H, Westwood M, Moghaddam A, Gatter KC, Bicknell R, Harris AL (1996) Expression of the angiogenic factor thymidine phosphorylase/platelet derived endothelial cell growth factor in primary bladder cancers. Cancer Res 56: 4799-4804
22. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, Carroll P, Dahiya R (2000) Frequent genotype changes at -308, and 488 regions of the tumour necrosis factor alpha gene in patients with prostate cancer. J Urol 163: 1584-1587
23. Sander B, Damm O, Gustafsson B, Anderson U, Hakansson L (1996) Localization of IL-I, IL-2, IL-4, IL-8 and TNF in superficial bladder tumours treated with intravesical bacillus Calmette-Guerrin. J Urol 156: 536-541
24. Sands BE (1999) New biologic agents: a critical appraisal. Curr Gastroenterol Rep 1: 470-475
25. Shin JS, Park JH, Kim JD, Lee JM, SJK (1995) Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guerin. Clin Exp Immunol 100: 26-31
26. Spencer-Green G (2000) Etanercept (Enbrel): update on therapeutic use. Ann Rheum Dis 59 (Suppl 1): i46-i49
27. Stonehill WH, Dmochowski RR, Patterson AL, Cox CE (1996) Risk factors for bladder tumors in spinal cord injury patients. J Urol 155: 1248-1250
28. Taniguchi K, Koga S, Nishikido M, Yamashita S, Sakuragi T, Kanetake H, Saito Y (1999) Systemic immune response after intravesical instillation of bacille Calmette-Guerin (BCG) for superficial bladder cancer. Clin Exp Immunol 115: 131-135
29. Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, Mckenzie FE, Gribben JG, Hartl D, Yunis EJ, Goldfield AE (1998) Identification of three new single nucleotide polymorphisms in the human tumour necrosis factor alpha gene promoter. Tissue Antigens 52: 359-367
30. Verweij CL (1999) Tumour necrosis factor gene polymorphisms as severity markers in rheumatoid arthritis. Ann Rheum Dis 58 (Suppl 1): I20-I26
31. Warzocha K, Ribeiro P, Bienvenu J, Roy P, Charlot C, Rigal D, Coiffier B, Salles G (1998) Genetic polymorphisms in the tumour necrosis factor locus influence non-Hodgkin's lymphoma outcome. Blood 91: 3574-3581
32. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177; 557-560
33. Wilson AG, Symons JA, Mcdowell TI, Mcdevitt HO, Duff GW (1997) Effects of a polymorphism in the human tumour necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 94: 3195-3199
34. Winsey SL, Haldar NA, Marsh HP, Bunce M, Marshall SE, Harris AL, Wojnarowska F, Welsh KI (2000) A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 60: 5612-5616